| 07.08 14:57 | dpa-AFX: Pre-market Movers: SCPX, GTHX, TLIS, ZCMD, EBS. |
| 07.08 14:02 | dpa-AFX: Charles River Laboratories International Q2 24 Earnings Conference Call At 9:00 AM ET |
| 07.08 13:37 | dpa-AFX: ROUNDUP: Charles River Laboratories Slashes FY24 Outlook |
| 07.08 13:17 | dpa-AFX: Charles River Laboratories International Inc. Q2 Profit Decreases, But Beats Estimates |
| 07.08 13:14 | dpa-AFX: *CHARLES RIVER LABORATORIES INTERNATIONAL INC. (CRL) ANNOUNCES $1 BLN STOCK REPURCHASE PLAN |
| 07.08 13:13 | dpa-AFX: *CHARLES RIVER LABORATORIES ANNOUNCES NEW SHARE REPURCHASE PROGRAM OF $1.0 BLN |
| 07.08 13:12 | dpa-AFX: *CHARLES RIVER LABORATORIES NOW EXPECTS GAAP EPS OF $5.65 - $5.95, NON-GAAP EPS OF $9.90 - $10.20 |
| 07.08 13:11 | dpa-AFX: *CHARLES RIVER LABORATORIES Q2 OPERATING INCOME $151.65 MLN VS. $164.95 MLN LAST YEAR |
| 07.08 13:11 | dpa-AFX: *CHARLES RIVER LABORATORIES Q2 TOTAL REVENUE $1.026 BLN VS. $1.059 BLN LAST YEAR |
| 07.08 13:11 | dpa-AFX: *CHARLES RIVER LABORATORIES Q2 NET INCOME $94.08 MLN VS. $97.02 MLN LAST YEAR |
| 07.08 13:04 | dpa-AFX: *CHARLES RIVER LABORATORIES Q2 GAAP EPS $1.74: NON-GAAP EPS $2.80 |
| 25.06 14:14 | dpa-AFX: *CHARLES RIVER LABORATORIES PARTNERS WITH GATES INSTITUTE FOR LENTIVIRAL VECTOR MANUFACTURING |
| 25.06 14:14 | dpa-AFX: *CHARLES RIVER LABORATORIES PARTNERS WITH GATES INSTITUTE FOR LENTIVIRAL VECTOR MANUFACTURING |
| 25.06 14:14 | dpa-AFX: *CHARLES RIVER LABORATORIES PARTNERS WITH GATES INSTITUTE FOR LENTIVIRAL VECTOR MANUFACTURING |
| 25.06 14:14 | dpa-AFX: *CHARLES RIVER LABORATORIES PARTNERS WITH GATES INSTITUTE FOR LENTIVIRAL VECTOR MANUFACTURING |
| 25.06 14:14 | dpa-AFX: *CHARLES RIVER LABORATORIES PARTNERS WITH GATES INSTITUTE FOR LENTIVIRAL VECTOR MANUFACTURING |
| 06.06 10:17 | dpa-AFX: *GOLDMAN STARTS CHARLES RIVER LABORATORIES WITH 'BUY' - PRICE TARGET 290 USD |
| 06.06 10:17 | dpa-AFX: *GOLDMAN STARTET CHARLES RIVER LABORATORIES MIT 'BUY' - ZIEL 290 USD |
|
|
